NOVARTIS | ASHOK-ALCO | NOVARTIS/ ASHOK-ALCO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.2 | 35.2 | 77.3% | View Chart |
P/BV | x | 3.4 | 1.0 | 336.7% | View Chart |
Dividend Yield | % | 4.5 | 1.1 | 422.8% |
NOVARTIS ASHOK-ALCO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
ASHOK-ALCO Mar-23 |
NOVARTIS/ ASHOK-ALCO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 105 | 726.9% | |
Low | Rs | 554 | 62 | 893.5% | |
Sales per share (Unadj.) | Rs | 153.4 | 60.3 | 254.6% | |
Earnings per share (Unadj.) | Rs | 41.9 | 4.9 | 854.3% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 6.7 | 658.5% | |
Dividends per share (Unadj.) | Rs | 47.50 | 1.00 | 4,750.0% | |
Avg Dividend yield | % | 7.2 | 1.2 | 602.2% | |
Book value per share (Unadj.) | Rs | 314.2 | 94.2 | 333.6% | |
Shares outstanding (eoy) | m | 24.69 | 4.60 | 536.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 1.4 | 309.8% | |
Avg P/E ratio | x | 15.7 | 17.0 | 92.3% | |
P/CF ratio (eoy) | x | 14.9 | 12.4 | 119.8% | |
Price / Book Value ratio | x | 2.1 | 0.9 | 236.4% | |
Dividend payout | % | 113.5 | 20.4 | 556.0% | |
Avg Mkt Cap | Rs m | 16,262 | 384 | 4,233.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 67 | 531.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 277 | 1,366.4% | |
Other income | Rs m | 581 | 44 | 1,324.3% | |
Total revenues | Rs m | 4,369 | 321 | 1,360.6% | |
Gross profit | Rs m | 651 | -5 | -12,007.4% | |
Depreciation | Rs m | 61 | 8 | 719.7% | |
Interest | Rs m | 18 | 2 | 1,073.6% | |
Profit before tax | Rs m | 1,154 | 28 | 4,059.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 6 | 2,047.7% | |
Profit after tax | Rs m | 1,034 | 23 | 4,585.6% | |
Gross profit margin | % | 17.2 | -2.0 | -879.0% | |
Effective tax rate | % | 10.4 | 20.7 | 50.4% | |
Net profit margin | % | 27.3 | 8.1 | 335.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 405 | 1,940.6% | |
Current liabilities | Rs m | 2,683 | 128 | 2,091.4% | |
Net working cap to sales | % | 136.7 | 99.9 | 136.9% | |
Current ratio | x | 2.9 | 3.2 | 92.8% | |
Inventory Days | Days | 1,201 | 22 | 5,456.8% | |
Debtors Days | Days | 35 | 2,570 | 1.4% | |
Net fixed assets | Rs m | 12,656 | 138 | 9,168.9% | |
Share capital | Rs m | 123 | 46 | 268.3% | |
"Free" reserves | Rs m | 7,634 | 387 | 1,971.5% | |
Net worth | Rs m | 7,757 | 433 | 1,790.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 543 | 3,777.7% | |
Interest coverage | x | 66.9 | 18.4 | 363.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0.5 | 36.2% | |
Return on assets | % | 5.1 | 4.4 | 115.1% | |
Return on equity | % | 13.3 | 5.2 | 256.1% | |
Return on capital | % | 15.1 | 6.9 | 217.7% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 61 | 1,540.8% | |
Net fx | Rs m | -866 | -61 | 1,410.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 3 | 13,293.8% | |
From Investments | Rs m | -1,533 | 59 | -2,611.6% | |
From Financial Activity | Rs m | -305 | -16 | 1,908.6% | |
Net Cashflow | Rs m | -1,389 | 46 | -3,015.0% |
Indian Promoters | % | 0.0 | 54.8 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 2.5 | 28.7% | |
FIIs | % | 0.2 | 2.5 | 7.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 45.2 | 64.8% | |
Shareholders | 41,239 | 4,199 | 982.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA OPTIEMUS INFRACOM
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | ASHOK-ALCO | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.42% | -2.55% | -1.91% |
1-Month | 1.10% | -24.63% | -3.64% |
1-Year | 68.66% | 3.28% | 47.69% |
3-Year CAGR | 17.41% | -1.21% | 11.83% |
5-Year CAGR | 9.01% | 13.45% | 20.01% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the ASHOK-ALCO share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of ASHOK-ALCO the stake stands at 54.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of ASHOK-ALCO.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
ASHOK-ALCO paid Rs 1.0, and its dividend payout ratio stood at 20.4%.
You may visit here to review the dividend history of Novartis, and the dividend history of ASHOK-ALCO.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on negative note, Indian benchmark indices slipped further as the session progressed and ended Thursday on Weak note.